Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Solid Profits from Medical Devices -- China Medical...
Ultrasound Device Ablates Tumors -- China Medical...
China Medical Technologies received approval to market...
Globally, M&A activity dropped 42% in Q3. Against...
China Medical will spend $28.8 million to acquire Beijing...
The interaction in biopharma activity between China and...
The ChinaBio® Stock Index, comprised of 17...
China Medical Technologies, Inc. was awarded the...
China Medical Technologies, which produces in-vitro...
Japan-based Daiichi Sankyo will buy a majority stake in...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
